<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="natural source of antioxidants, tyrosinase and Î±-amylase inhibitors, and anti-chronic" exact="myeloid leukemia" post="(CML) agents which may be useful in future therapeutics"/>
 <result pre="source of antioxidants, tyrosinase and Î±-amylase inhibitors, and anti-chronic myeloid" exact="leukemia" post="(CML) agents which may be useful in future therapeutics"/>
 <result pre="alternative medicines. Andropogon virginicus antioxidants Î±-amylase inhibitor tyrosinase inhibitor anti-chronic" exact="myeloid leukemia" post="anti-diabetes anti-skin aging high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry"/>
 <result pre="medicines. Andropogon virginicus antioxidants Î±-amylase inhibitor tyrosinase inhibitor anti-chronic myeloid" exact="leukemia" post="anti-diabetes anti-skin aging high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry"/>
 <result pre="the pathogenesis of numerous chronic diseases including diabetes, aging, and" exact="cancer" post="[9]. Concretely, the inflammatory process can exacerbate oxidative stress"/>
 <result pre="the symptom of type 2 diabetes and skin hyperpigmentation. In" exact="cancer" post="cases, chronic myeloid leukemia (CML) is a severe disorder,"/>
 <result pre="of type 2 diabetes and skin hyperpigmentation. In cancer cases," exact="chronic myeloid leukemia" post="(CML) is a severe disorder, caused by the unregular"/>
 <result pre="type 2 diabetes and skin hyperpigmentation. In cancer cases, chronic" exact="myeloid leukemia" post="(CML) is a severe disorder, caused by the unregular"/>
 <result pre="2 diabetes and skin hyperpigmentation. In cancer cases, chronic myeloid" exact="leukemia" post="(CML) is a severe disorder, caused by the unregular"/>
 <result pre="solution in preventing the development of CML. Furthermore, the synergic" exact="suppression" post="against oxidative stress, tyrosinase and Î±-amylase enzymes, and K562"/>
 <result pre="Î±-amylase inhibitor. The extracts including E-Anvi and B-Anvi display insignificant" exact="suppression" post="on Î±-amylase. At the concentration of 10 mg/mL, they"/>
 <result pre="twice weaker than E-Anvi. The remaining fractional extracts reveal insignificant" exact="suppression" post="against K562 cell viability. In the case of Meg-01"/>
 <result pre="Meg-01 as well. Moreover, via all tested assays, the synergic" exact="suppression" post="of extracts from A. virginicus against various factors involving"/>
 <result pre="studies. The inhibition of this compound on different types of" exact="cancer" post="cells and relevant modes of action have been globally"/>
 <result pre="J. Hepatol.2012201285317510.1155/2012/85317522500241 14.CachofeiroV.GoicocheaM.de VinuesaS.D.OubinaP.LaheraV.LunoJ.Oxidative stress and inflammation, a link between" exact="chronic kidney disease" post="and cardiovascular diseaseKidney Int. Suppl.2008111S4S910.1038/ki.2008.516 15.TuckerP.S.ScanlanA.T.DalboV.J.Chronic kidney disease influences"/>
 <result pre="27.NIHâ€&quot;National Cancer InstituteAvailable online: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/white-blood-cell?fbclid=IwAR1Jr1RfMklHWtlLj2eQ_HdJp9xY6-h8OQHhYkg2fnQWBeDLJbzscm9tLO8(accessed on 20 October 2020) 28.KoefflerH.P.GoldeD.W.Human" exact="myeloid leukemia" post="cell lines: A reviewBlood19805634435010.1182/blood.V56.3.344.3446996765 29.TakeuchiK.OguraM.SaitoH.SatohM.TakeuchiM.Production of platelet-like particles by"/>
 <result pre="Cancer InstituteAvailable online: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/white-blood-cell?fbclid=IwAR1Jr1RfMklHWtlLj2eQ_HdJp9xY6-h8OQHhYkg2fnQWBeDLJbzscm9tLO8(accessed on 20 October 2020) 28.KoefflerH.P.GoldeD.W.Human myeloid" exact="leukemia" post="cell lines: A reviewBlood19805634435010.1182/blood.V56.3.344.3446996765 29.TakeuchiK.OguraM.SaitoH.SatohM.TakeuchiM.Production of platelet-like particles by"/>
 <result pre="A reviewBlood19805634435010.1182/blood.V56.3.344.3446996765 29.TakeuchiK.OguraM.SaitoH.SatohM.TakeuchiM.Production of platelet-like particles by a human megakaryoblastic" exact="leukemia" post="cell line (Meg-01)Exp. Cell Res.199119322322610.1016/0014-4827(91)90560-H1995298 30.OguraM.MorishimaY.OhnoR.KatoY.HirabayashiN.NaguraH.SaitoH.Establishment of a novel"/>
 <result pre="line (Meg-01)Exp. Cell Res.199119322322610.1016/0014-4827(91)90560-H1995298 30.OguraM.MorishimaY.OhnoR.KatoY.HirabayashiN.NaguraH.SaitoH.Establishment of a novel human megakaryoblastic" exact="leukemia" post="cell line, MEG-01, with positive Philadelphia chromosomeBlood1985661384139210.1182/blood.V66.6.1384.13842998511 31.BjelakovicG.NikolovaD.GluudL.L.SimonettiR.G.GluudC.Mortality in"/>
 <result pre="of combined folic acid, vitamin B6, and vitamin B12 on" exact="cancer" post="risk in women: A randomized trialJAMA20083002012202110.1001/jama.2008.55518984888 33.SessoH.D.BuringJ.E.ChristenW.G.KurthT.BelangerC.MacFadyenJ.BubesV.MansonJ.E.GlynnR.J.GazianoJ.M.Vitamins E and"/>
 <result pre="randomized trialJAMA20083002012202110.1001/jama.2008.55518984888 33.SessoH.D.BuringJ.E.ChristenW.G.KurthT.BelangerC.MacFadyenJ.BubesV.MansonJ.E.GlynnR.J.GazianoJ.M.Vitamins E and C in the prevention of" exact="cardiovascular disease" post="in men: The physiciansâ€™ health study II randomized controlled"/>
 <result pre="55.SheejaL.LakshmiD.BharadwajS.ParveenK.S.Anticancer activity of phytol purified from Gracilaria edulis against human" exact="breast cancer" post="cell line (MCF-7)Int. J. Curr. Sci.2016193646 56.de AlencarM.V.O.B.IslamM.T.de LimaR.M.T.PazM.F.C.J.Dos"/>
 <result pre="activity of phytol purified from Gracilaria edulis against human breast" exact="cancer" post="cell line (MCF-7)Int. J. Curr. Sci.2016193646 56.de AlencarM.V.O.B.IslamM.T.de LimaR.M.T.PazM.F.C.J.Dos"/>
 <result pre="L. induces G2/M cell cycle arrest and apoptosis through c-Myc" exact="suppression" post="in MCF-7 and A549 cellsJ. Ethnopharmacol.201214180380910.1016/j.jep.2012.03.01422440953 60.TeschkeR.XuanT.D.Active nature-based ingredients"/>
</results>
